Synthesis and structure-activity relationship study of antidiabetic penta-O-galloyl-D-glucopyranose and its analogues

作者: Yulin Ren , Klaus Himmeldirk , Xiaozhuo Chen

DOI: 10.1021/JM060087K

关键词: Structure–activity relationshipChemistryInsulinGlucose uptakeInsulin receptorAdipocyteEndocrinologyInternal medicineDiabetes mellitusGlucose transporterCarbohydrate metabolism

摘要: The rapid increase of obesity-associated diabetes has created urgent demands for more effective antidiabetic therapies and pharmaceuticals that are able to address the problems hyperglycemia weight gain simultaneously. Our previous studies indicated alpha- beta-anomers penta-O-galloyl-D-glucopyranose (PGG), 2 3, act as insulin mimetics bind activate receptor, stimulate glucose transport in adipocytes, reduce blood levels diabetic obese animals. In addition, they inhibit differentiation preadipocytes into adipocytes. These activities suggest 3 may without increasing adiposity. To investigate structure-activity relationship four series novel compounds were prepared their stimulatory measured using a radioactive uptake bioassay. assay results indicate both galloyl groups critical activity 3. It appears core provides an optimal scaffold present with correct spatial orientation induce activity. Moreover, linked 1, 2, 4 positions essential, while group connected 6 position is unnecessary induction discovery two related compounds, 6-deoxytetra-O-galloyl-alpha-D-glucopyranose (43) tetra-O-galloyl-alpha-D-xylopyranose (59), also possess suggests be further modified around modulate enhance its efficacy. test this hypothesis, we developed new synthetic method allows stereoselective preparation derivatives on C-6. We found 6-chloro-6-deoxy-1,2,3,4-tetra-O-galloyl-alpha-D-glucopyranose (80) exhibits significantly higher than 2. Its comparable insulin.

参考文章(36)
Peter G. Kopelman, Obesity as a medical problem Nature. ,vol. 404, pp. 635- 643 ,(2000) , 10.1038/35007508
Masahira Hattori, Todd D. Taylor, Part three in the book of genes Nature. ,vol. 414, pp. 854- 855 ,(2001) , 10.1038/414854A
Stéphane Rocchi, Frédéric Picard, Joseph Vamecq, Laurent Gelman, Noelle Potier, Denis Zeyer, Laurent Dubuquoy, Pierre Bac, Marie-France Champy, Kelli D. Plunket, Lisa M. Leesnitzer, Steven G. Blanchard, Pierre Desreumaux, Dino Moras, Jean-Paul Renaud, Johan Auwerx, A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity Molecular Cell. ,vol. 8, pp. 737- 747 ,(2001) , 10.1016/S1097-2765(01)00353-7
Alan R Saltiel, Jeffrey E Pessin, Insulin signaling pathways in time and space Trends in Cell Biology. ,vol. 12, pp. 65- 71 ,(2002) , 10.1016/S0962-8924(01)02207-3
Bernhard Neises, Wolfgang Steglich, Simple Method for the Esterification of Carboxylic Acids Angewandte Chemie. ,vol. 17, pp. 522- 524 ,(1978) , 10.1002/ANIE.197805221
Roger Corder, Julie A. Douthwaite, Delphine M. Lees, Noorafza Q. Khan, Ana Carolina Viseu dos Santos, Elizabeth G. Wood, Martin J. Carrier, Endothelin-1 synthesis reduced by red wine Nature. ,vol. 414, pp. 863- 864 ,(2001) , 10.1038/414863A
F. P. Ottensmeyer, Daniel R. Beniac, Robert Z.-T. Luo, Cecil C. Yip, Mechanism of Transmembrane Signaling: Insulin Binding and the Insulin Receptor† Biochemistry. ,vol. 39, pp. 12103- 12112 ,(2000) , 10.1021/BI0015921
Mathias Z. Strowski, Zhihua Li, Deborah Szalkowski, Xiaolan Shen, Xiao-Ming Guan, Stefan Jüttner, David E. Moller, Bei B. Zhang, Small-molecule insulin mimetic reduces hyperglycemia and obesity in a nongenetic mouse model of type 2 diabetes. Endocrinology. ,vol. 145, pp. 5259- 5268 ,(2004) , 10.1210/EN.2004-0610
Makoto Nishizawa, Takashi Yamagishi, Gen-Ichiro Nonaka, Itsuo Nishioka, Mark A. Ragan, Gallotannins of the freshwater green alga Spirogyra sp. Phytochemistry. ,vol. 24, pp. 2411- 2413 ,(1985) , 10.1016/S0031-9422(00)83053-8